Skip to content

Perceptions and Representations of Cancer Chemotherapy

Perceptions and Representations of Cancer Chemotherapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02851160
Acronym
chemotherapy
Enrollment
75
Registered
2016-08-01
Start date
2015-03-31
Completion date
2015-12-31
Last updated
2016-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care. Framework type of method using grounded theory

Detailed description

The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory. The objective of the research: To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational. To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy

Interventions

OTHERsemi-structured interview conducted by a clinical psychologist

semi-structured interview conducted by a clinical psychologist

OTHERsemi-structured interview conducted by a psychiatrist specialized in psycho-oncology

semi-structured interview conducted by a psychiatrist specialized in psycho-oncology

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment * 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery * 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Exclusion criteria

* NA

Design outcomes

Primary

MeasureTime frameDescription
The semi-structured interview1 day (day of inclusion)The interview will be analyzed in a framework type of method (grounded theory) in accordance with the guidelines coreq.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026